Pharma Companies Quotes

The American Academy of Nutrition and Dietetics is sponsored by Coca-Cola.

Repeat after me: pharma being shit does not mean magic beans cure cancer.

Pick a leader who will make their citizens proud. One who will stir the hearts of the people, so that the sons and daughters of a given nation strive to emulate their leader's greatness. Only then will a nation be truly great, when a leader inspires and produces citizens worthy of becoming future leaders, honorable decision makers and peacemakers. And in these times, a great leader must be extremely brave. Their leadership must be steered only by their conscience, not a bribe.

Pick a leader who will keep jobs in your country by offering companies incentives to hire only within their borders, not one who allows corporations to outsource jobs for cheaper labor when there is a national employment crisis. Choose a leader who will invest in building bridges, not walls. Books, not weapons. Morality, not corruption. Intellectualism and wisdom, not ignorance. Stability, not fear and terror. Peace, not chaos. Love, not hate. Convergence, not segregation. Tolerance, not discrimination. Fairness, not hypocrisy. Substance, not superficiality. Character, not immaturity. Transparency, not secrecy. Justice, not lawlessness. Environmental improvement and preservation, not destruction. Truth, not lies.

Suicide rates have not slumped under the onslaught of antidepressants, mood-stabilizers, anxiolytic and anti-psychotic drugs; the jump in suicide rates suggests that the opposite is true. In some cases, suicide risk skyrockets once treatment begins (the patient may feel not only penalized for a justifiable reaction, but permanently stigmatized as malfunctioning). Studies show that self-loathing sharply decreases only in the course of cognitive-behavioral treatment.

Problems in medicine do not mean that homeopathic sugar pills work; just because there are problems with aircraft design, that doesn't mean that magic carpets really fly.

Big Pharma needs sick people to prosper. Patients, not healthy people, are their customers. If everybody was cured of a particular illness or disease, pharmaceutical companies would lose 100% of their profits on the products they sell for that ailment. What all this means is because modern medicine is so heavily intertwined with the financial profits culture, it’s a sickness industry more than it is a health industry.

It is clear from the evidence presented in this book that the pharmaceutical industry does a biased job of disseminating evidence - to be surprised by this would be absurd - whether it is through advertising, drug reps, ghostwriting, hiding data, bribing people, or running educational programmes for doctors.

The American Academy of Pediatrics officially supports breastfeeding, but receives about half a million dollars from Ross, manufacturers of Similac infant formula.

The current regulations -- for companies, doctors and researchers -- create perverse incentives; and we'll have better luck fixing those broken systems than we will ever have trying to rid the world of avarice

Some have estimated that the pharmaceutical industry overall spends about twice as much on marketing and promotion as it does on research and development.

So, if we're to make any sense of the mess that the pharmaceutical industry - and my profession - has made of the academic literature, then we need an amnesty: we need a full and clear declaration of all the distortions, on missing data, ghostwriting, and all the other activity described in this book, to prevent the ongoing harm that they still cause.

No wonder big pharma will do almost anything to protect exclusive marketing rights, despite the fact that doing so flies in the face of all its rhetoric about the free market.

I hope that you will be asked to participate in a trial at some stage in your disease

But you can't put a corporation in jail; you just take their money, and it's not really their money anyway.

The corporation feels no pain.

No,” said a third student. “Novartis is a public company. It’s not the boss or the board who decides. It’s the shareholders. If the board changes its priorities the shareholders will just elect a new board.” “That’s right,” I said. “It’s the shareholders who want this company to spend their money on researching rich people’s illnesses. That’s how they get a good return on their shares.” So there’s nothing wrong with the employees, the boss, or the board, then. “Now, the question is”—I looked at the student who had first suggested the face punching—“who owns the shares in these big pharmaceutical companies?” “Well, it’s the rich.” He shrugged. “No. It’s actually interesting because pharmaceutical shares are very stable. When the stock market goes up and down, or oil prices go up and down, pharma shares keep giving a pretty steady return. Many other kinds of companies’ shares follow the economy—they do better or worse as people go on spending sprees or cut back—but the cancer patients always need treatment. So who owns the shares in these stable companies?” My young audience looked back at me, their faces like one big question mark. “It’s retirement funds.” Silence. “So maybe I don’t have to do any punching, because I will not meet the shareholders. But you will. This weekend, go visit your grandma and punch her in the face. If you feel you need someone to blame and punish, it’s the seniors and their greedy need for stable stocks.

Fauci generation”—children born after his elevation to NIAID kingpin in 1984— the sickest generation in American history, and has made Americans among the least healthy citizens on the planet. His obsequious subservience to the Big Ag, Big Food, and pharmaceutical companies has left our children drowning in a toxic soup of pesticide residues, corn syrup, and processed foods, while also serving as pincushions for 69 mandated vaccine doses by age 18—none of them properly safety tested.55

If your drug didn’t win overall in your trial, you can chop up the data in lots of different ways, to try and see if it won in a subgroup: maybe it works brilliantly in Chinese men between fifty-six and seventy-one. This is as stupid as playing ‘Best of three … Best of five…’ And yet it is commonplace.

So what steps can a regulator take when it has established that there is a problem? In very extreme cases it can remove a drug from the market (although in the US, technically drugs usually stay on the market, with the FDA advising against their use). More commonly it will issue a warning to doctors through one of its drug safety updates, a ‘Dear Doctor’ letter, or by changing the ‘label’ (confusingly, in reality, a leaflet) that comes with the drug. Drug-safety updates are sent to most doctors, though it’s not entirely clear whether they are widely read. But, amazingly, when a regulator decides to notify doctors about a side effect, the drug company can contest this, and delay the notice being sent out for months, or even years.

At this time we should take a brife moment to mention quacks: alternative therapists who sell vitamins and homeopathy sugar pills [the latter of which, by definition, contain no active ingredients], which perform no better than placebo in fair tests, and who use even cruder marketing tricks than the ones described in this book. In these people profit at all from the justified anger that people feel towards the pharmaceutical industry, then it comes at the expense of genuinely constructive activity. Selling ineffective sugar pills is not a meaningful policy response to the regulatory failure we have seen in this book

In medicine, brand identities are irrelevant, and there’s a factual, objective answer to whether one drug is the most likely to improve a patient’s pain, suffering and longevity. Marketing, therefore, one might argue, exists for no reason other than to pervert evidence-based decision-making in medicine.

we hope that this will help reduce the chances of real-world outcomes, like heart attack and death, both of which occur at a higher rate in people with

Can the CEO of a pharmaceutical company prioritize opioid addiction as a top concern if they are making a profit from opioids?

in 2008, shortly after being elected President, Barack Obama demonstrated to many academics and doctors that he had a clear understanding of the deep problems in health care, by committing to spend $1 billion on head-to-head trials of commonly used treatments, in order to find out which is best. In return he was derided by right-wing critics as ‘anti-industry’.

Doctors are generally nice people, and eager to please. They will get bounced into giving people what they want, and a lot of patients have been persuaded, through whatever social processes are at play in the world, that pills fix things. I'll rephrase that for something that's coming later in this chapter: a lot of people have been convinced that they're patients.

Aside from all this, for several of the most important and enduring problems in medicine, we have no idea what the best treatment is, because it’s not in anyone’s financial interest to conduct any trials at all.

Classically, cosmetics companies will take highly theoretical, textbookish information about the way that cells work—the components at a molecular level or the behavior of cells in a glass dish—and then pretend it’s the same as the ultimate issue of whether something makes you look nice. “This molecular component,” they say, with a flourish, “is crucial for collagen formation.” And that will be perfectly true (along with many other amino acids which are used by your body to assemble protein in joints, skin, and everywhere else), but there is no reason to believe that anyone is deficient in it or that smearing it on your face will make any difference to your appearance. In general, you don’t absorb things very well through your skin, because its purpose is to be relatively impermeable. When you sit in a bath of baked beans for charity, you do not get fat, nor do you start farting.

Here we will see that pharmaceutical companies spend tens of billions of pounds every year trying to change the treatment decisions of doctors: in fact, they spend twice as much on marketing and advertising as they do on the research and development of new drugs. Since we all want doctors to prescribe medicine based on evidence, and evidence is universal, there is only one possible reason for such huge spends: to distort evidence-based practice.

Amateur critics often like to dismiss anecdotes as ‘unscientific’, but this is wrong: anecdotes are weaker evidence than trials, but they are not without value, and are often the first sign of a problem (or an unexpected benefit).

[...] I’m very grateful to all the many companies and people who, by their optimistically bad behaviour under fire, have given narrative colour to what might otherwise have been some very dry explanations of basic statistical principles.

Thus, if any FDA-approved drug like hydroxychloroquine (or ivermectin) proved effective against COVID, pharmaceutical companies would no longer be legally allowed to fast-track their billion-dollar vaccines to market under Emergency Use Authorization.

The younger generation of Sacklers were becoming increasingly involved in the company. Richard officially joined the board in 1990, along with his brother, Jonathan, and Kathe and her sister, Ilene. The following year, the family created a new company, Purdue Pharma.

The very Internet companies that snookered us all with the promise of democratizing communications made it impermissible for Americans to criticize their government or question the safety of pharmaceutical products; these companies propped up all official pronouncements while scrubbing all dissent. The same Tech/Data and Telecom robber barons, gorging themselves on the corpses of our obliterated middle class, rapidly transformed America’s once-proud democracy into a censorship and surveillance police state from which they profit at every turn.

It remains an enduring mystery just which powerful figure(s) caused the world’s two most prestigious scientific journals, The Lancet and the New England Journal of Medicine (NEJM), to publish overtly fraudulent studies from a nonexistent database owned by a previously unknown company. Anthony Fauci and the vaccine cartel celebrated the Lancet and NEJM papers on May 22, 2020

The idea that depression is caused by low serotonin levels in the brain is now deeply embedded in popular folklore, and people with no neuroscience background at all will routinely incorporate phrases about it into everyday discussion of their mood, just to keep their serotonin levels up. Many people also don't know that this is how antidepressant drugs work: depression is caused by low serotonin, so you need drugs which raise the serotonin levels in your brain, like SSRI antidepressants, which are 'selective serotonin reuptake inhibitors'. But this theory is wrong. The 'serotonin hypothesis' for depression, as it is known, was always shaky, and the evidence now is hugely contradictory ... But in popular culture the depression-serotonin theory is proven and absolute, because it has been marketed so effectively.

Over the last fifty years at NIH, Dr. Fauci has played a leading role in Big Pharma’s engineered demolition of American health and democracy, working hand in glove with pharmaceutical companies to overcome federal regulatory obstacles and transform the NIH and NIAID into a single-minded vehicle for development, promotion, and marketing of patented pharmaceutical products, including vaccines and vaccine-like products.

the fact is, our relationships to these corporations are not unambiguous. some memebers of negativland genuinely liked pepsi products. mca grew up loving star wars and didn't mind having his work sent all over the united states to all the "cool, underground magazines" they were marketing to--why would he? sam gould had a spiritual moment in the shower listening to a cd created, according to sophie wong, so that he would talk about tylenol with his independent artist friends--and he did. many of my friends' daughters will be getting american girl dolls and books as gifts well into the foreseeable future. some skateboarders in washington, dc, were asked to create an ad campaign for the east coast summer tour, and they all love minor threat--why not use its famous album cover? how about shilling for converse? i would have been happy to ten years ago. so what's really changed? the answer is that two important things have changed: who is ultimately accountable for veiled corporate campaigns that occasionally strive to obsfucate their sponsorship and who is requesting our participation in such campaigns. behind converse and nike sb is nike, a company that uses shit-poor labor policies and predatory marketing that effectively glosses over their shit-poor labor policies, even to an audience that used to know better. behind team ouch! was an underground-savvy brainreservist on the payroll of big pharma; behind the recent wave of street art in hip urban areas near you was omd worldwide on behalf of sony; behind your cool hand-stenciled vader shirt was lucasfilm; and behind a recent cool crafting event was toyota. no matter how you participated in these events, whether as a contributor, cultural producer, viewer, or even critic, these are the companies that profited from your attention.

In an era when whole cities like Flint, Michigan, have had their water poisoned; when gas companies tell you that fracking is safe, never mind the earthquakes and flammable tap water; when Monsanto lobbies ceaselessly against attempts to ban its herbicide Roundup despite it having been credibly linked with cancer; and when Big Pharma peddled the drugs that set off the opioid crisis, it is entirely rational to be skeptical toward monopolistic power.

One of the best-kept secrets in all of health care — understood by few doctors — is that the peer reviewers, medical journal editors, and guideline writers, who are assumed to be performing due diligence to ensure the accuracy and completeness of the data reported from company-sponsored studies, do not have access to the real data from these trials. The published reports that doctors accept as fully vetted scientific evidence can be more accurately described as unverified data summaries prepared largely by or for the sponsoring drug companies.

The most notorious story is the Trovan antibiotic study conducted by Pfizer in Kano, Nigeria, during a meningitis epidemic. An experimental new antibiotic was compared, in a randomised trial, with a low dose of a competing antibiotic that was known to be effective. Eleven children died, roughly the same number from each group. Crucially, the participants were apparently not informed about the experimental nature of the treatments, and moreover, they were not informed that a treatment known to be effective was available, immediately, from Médecins sans Frontières next door at the very same facility. Pfizer argued in court – successfully – that there was no international norm requiring it to get informed consent for a trial involving experimental drugs in Africa, so the cases relating to the trial should be heard in Nigeria only. That’s a chilling thing to hear a company claim about experimental drug trials, and it was knocked back in 2006 when the Nigerian Ministry of Health released its report on the trial. This stated that Pfizer had violated Nigerian law, the UN Convention on the Rights of the Child and the Declaration of Helsinki.

different subject. The story of the serotonin hypothesis for depression, and its enthusiastic promotion by drug companies, is part of a wider process that has been called ‘disease-mongering’ or ‘medicalisation’, where diagnostic categories are widened, whole new diagnoses are invented, and normal variants of human experience are pathologised, so they can be treated with pills. One simple illustration of this is the recent spread of ‘checklists’ enabling the public to diagnose, or help diagnose, various medical conditions. In 2010, for example, the popular website WebMD launched a new test: ‘Rate your risk for depression: could you be depressed?’ It was funded by Eli Lilly, manufacturers of the antidepressant duloxetine, and this was duly declared on the page, though that doesn’t reduce the absurdity of what followed. The test consisted of ten questions, such as: ‘I feel sad or down most of the time’; ‘I feel tired almost every day’; ‘I have trouble concentrating’; ‘I feel worthless or hopeless’; ‘I find myself thinking a lot about dying’; and so on. If you answered ‘no’ to every single one of these questions – every single one – and then pressed ‘Submit’, the response was clear: ‘You may be at risk for major depression’.

So should patients born under Libra and Gemini be deprived of treatment? You would say no, of course, and that would make you wiser than many in the medical profession: the CCSG trial found that aspirin was effective at preventing stroke and death in men, but not in women;30 as a result, women were undertreated for a decade, until further trials and overviews showed a benefit. That is just one of many subgroup analyses that have misled us in medicine, often incorrectly identifying subgroups of people who wouldn’t benefit from a treatment that was usually effective. So, for example, we thought the hormone-blocking drug tamoxifen was no good for treating breast cancer in women if they were younger than fifty (we were wrong). We thought clotbusting drugs were ineffective, or even harmful, when treating heart attacks in people who’d already had a heart attack (we were wrong). We thought drugs called ‘ACE inhibitors’ stopped reducing the death rate in heart failure patients if they were also on aspirin (we were wrong). Unusually, none of these findings was driven by financial avarice: they were driven by ambition, perhaps; excitement at new findings, certainly; ignorance of the risks of subgroup analysis; and, of course, chance.

Like many doctors, I was frankly traumatized by some of the experiences I had early on in my career. When you lean over a patient in an emergency room, trying to bring a dead body back to life, you are entirely focused on the job at hand. On the other side of a thin curtain, you can hear that person’s husband or wife howling and wailing, knowing that the person they loved and lived with for fifty years is dying, begging the staff to do all they can, phoning their children, struggling to speak through tears to form the words and communicate the horror, telling them to come, quickly. I have memories from cubicles that I will never be able to deal with, and they upset me even now.

They write the steady stream of editorials that appear in local and national newspapers to reinforce the hackneyed orthodoxies of the pharmaceutical paradigms—“all vaccines are safe and effective,” etc. They root out heresy by sitting on the state medical boards—the “Inquisition” courts—that censure and de-license dissident doctors. They control the medical journals and peer-review journal literature to fortify Pharma’s agenda. They teach on medical school faculties, populate journal editorial boards, and chair university departments. They supervise hospitals and chair hospital departments. They act as expert witnesses for pharmaceutical companies in civil court and the federal vaccine court. They present awards to one another.

Some have estimated that the pharmaceutical industry overall spends about twice as much on marketing and promotion as it does on research and development. Regardless of how those two figures compare to each other, the fact that they are in the same ballpark gives one pause, and this is worth mulling over in various contexts. For example, when a drug company refuses to let a developing country have affordable access to a new AIDS drug it’s because – the company says – it needs the money from sales to fund research and development on other new AIDS drugs for the future. If R&D is a fraction of the company’s outgoings, and it spends a similar amount on promotion, then this moral and practical argument doesn’t hold water quite so well.

Dr. Fauci’s business closures pulverized America’s middle class and engineered the largest upward transfer of wealth in human history. In 2020, workers lost $3.7 trillion while billionaires gained $3.9 trillion.46 Some 493 individuals became new billionaires,47 and an additional 8 million Americans dropped below the poverty line.48 The biggest winners were the robber barons—the very companies that were cheerleading Dr. Fauci’s lockdown and censoring his critics: Big Technology, Big Data, Big Telecom, Big Finance, Big Media behemoths (Michael Bloomberg, Rupert Murdoch, Viacom, and Disney), and Silicon Valley Internet titans like Jeff Bezos, Bill Gates, Mark Zuckerberg, Eric Schmidt, Sergey Brin, Larry Page, Larry Ellison, and Jack Dorsey.

Some have estimated that the pharmaceutical industry overall spends about twice as much on marketing and promotion as it does on research and development. Regardless of how those two figures compare to each other, the fact that they are in the same ballpark gives one pause, and this is worth mulling over in various contexts. For example, when a drug company refuses to let a developing country have affordable access to a new AIDS drug it’s because – the company says – it needs the money from sales to fund research and development on other new AIDS drugs for the future. If R&D is a fraction of the company’s outgoings, and it spends a similar amount on promotion, then this moral and practical argument doesn’t hold water quite so well. The scale of this spend is fascinating in itself, when you put it in the context of what we all expect from evidence-based medicine, which is that people will simply use the best treatment for the patient. Because when you pull away from the industry’s carefully fostered belief that this marketing activity is all completely normal, and stop thinking of drugs as being a consumer product like clothes or cosmetics, you suddenly realise that medicines marketing only exists for one reason. In medicine, brand identities are irrelevant, and there’s a factual, objective answer to whether one drug is the most likely to improve a patient’s pain, suffering and longevity. Marketing, therefore, one might argue, exists for no reason other than to pervert evidence-based decision-making in medicine.

Both studies in these respected publications relied on data from the Surgisphere Corporation, an obscure Illinois-based “medical education” company that claimed to somehow control an extraordinary global database boasting access to medical information from 96,000 patients in more than 600 hospitals.87 Founded in 2008, this sketchy enterprise had eleven employees, including a middling science fiction writer and a porn star/events hostess. Surgisphere claimed to have analyzed data from six continents and hundreds of hospitals that had treated patients with HCQ or CQ in real time. Someone persuaded the Lancet and the New England Journal of Medicine to publish two Surgisphere studies in separate articles on May 1 and 22. Like the other Gates-supported studies, the Lancet article portrayed HCQ as ineffective and dangerous.

The most widely cited figure for the number of women suffering from Female Sexual Dysfunction comes from 1999: according to this, some 43 per cent of all women have a medical problem around their sex drive.27 This survey was published in the Journal of the American Medical Association (JAMA), one of the most influential journals in the world. It looked at questionnaire data asking about things like lack of desire for sex, poor lubrication, anxiety over sexual performance, and so on. If you answered ‘yes’ to any one of these questions, you were labelled as having Female Sexual Dysfunction. For the avoidance of any doubt about the influence of this paper, it has – as of a sunny evening in March 2012 – been cited 1,691 times. That is a spectacular number of citations. At the time, no financial interest was declared by the study’s authors. Six months later, after criticism in the New York Times, two of the three authors declared consulting and advisory work for Pfizer.28 The company was gearing up to launch Viagra for the female market at this time, and had lots to gain from more women being labelled as having a medical sexual problem.

It would be a mistake to imagine that drug companies are the only people applying pressure for fast approvals. Patients can also feel they are being deprived of access to drugs, especially if they are desperate. In fact, in the 1980s and 1990s the key public drive for faster approvals came from an alliance forged between drug companies and AIDS activists such as ACT UP. At the time, HIV and AIDS had suddenly appeared out of nowhere, and young, previously healthy gay men were falling ill and dying in terrifying numbers, with no treatment available. We don’t care, they explained, if the drugs that are currently being researched for effectiveness might kill us: we want them, because we’re dying anyway. Losing a couple of months of life because a currently unapproved drug turned out to be dangerous was nothing, compared to a shot at a normal lifespan. In an extreme form, the HIV-positive community was exemplifying the very best motivations that drive people to participate in clinical trials: they were prepared to take a risk, in the hope of finding better treatments for themselves or others like them in the future. To achieve this goal they blocked traffic on Wall Street, marched on the FDA headquarters in Rockville, Maryland, and campaigned tirelessly for faster approvals.

Dr. Fauci’s business closures pulverized America’s middle class and engineered the largest upward transfer of wealth in human history. In 2020, workers lost $3.7 trillion while billionaires gained $3.9 trillion.46 Some 493 individuals became new billionaires,47 and an additional 8 million Americans dropped below the poverty line.48 The biggest winners were the robber barons—the very companies that were cheerleading Dr. Fauci’s lockdown and censoring his critics: Big Technology, Big Data, Big Telecom, Big Finance, Big Media behemoths (Michael Bloomberg, Rupert Murdoch, Viacom, and Disney), and Silicon Valley Internet titans like Jeff Bezos, Bill Gates, Mark Zuckerberg, Eric Schmidt, Sergey Brin, Larry Page, Larry Ellison, and Jack Dorsey. The very Internet companies that snookered us all with the promise of democratizing communications made it impermissible for Americans to criticize their government or question the safety of pharmaceutical products; these companies propped up all official pronouncements while scrubbing all dissent. The same Tech/Data and Telecom robber barons, gorging themselves on the corpses of our obliterated middle class, rapidly transformed America’s once-proud democracy into a censorship and surveillance police state from which they profit at every turn.

By March, front-line doctors around the world were spontaneously reporting miraculous results following early treatment with HCQ, and this prompted growing anxiety for Pharma. On March 13, a Michigan doctor and trader, Dr. James Todaro, M.D., tweeted his review of HCQ as an effective COVID treatment, including a link to a public Google doc.48,49 Google quietly scrubbed Dr. Todaro’s memo. This was six days before the President endorsed HCQ. Google apparently didn’t want users to think Todaro’s message was missing; rather, the Big Tech platform wanted the public to believe that Todaro’s memo never even existed. Google has a long history of suppressing information that challenges vaccine industry profits. Google’s parent company Alphabet owns several vaccine companies, including Verily, as well as Vaccitech, a company banking on flu, prostate cancer, and COVID vaccines.50,51 Google has lucrative partnerships with all the large vaccine manufacturers, including a $715 million partnership with GlaxoSmithKline.52 Verily also owns a business that tests for COVID infection.53 Google was not the only social media platform to ban content that contradicts the official HCQ narrative. Facebook, Pinterest, Instagram, YouTube, MailChimp, and virtually every other Big Tech platform began scrubbing information demonstrating HCQ’s efficacy, replacing it with industry propaganda generated by one of the Dr. Fauci/Gates-controlled public health agencies: HHS, NIH and WHO. When President Trump later suggested that Dr. Fauci was not being truthful about hydroxychloroquine, social media responded by removing his posts.

In March, at HHS’s request, several large pharmaceutical companies—Novartis, Bayer, Sanofi, and others—donated their inventory, a total of 63 million doses of hydroxychloroquine and 2 million of chloroquine, to the Strategic National Stockpile, managed by BARDA, an agency under the DHHS Assistant Secretary for Preparedness and Response.56 BARDA’s Director, Dr. Rick Bright, later claimed the chloroquine drugs were deadly, and he needed to protect the American public from them.57 Bright colluded with FDA to restrict use of the donated pills to hospitalized patients. FDA publicized the authorization using language that led most physicians to believe that prescribing the drug for any purpose was off-limits. But at the beginning of June, based on clinical trials that intentionally gave unreasonably high doses to hospitalized patients and failed to start the drug until too late, FDA took the unprecedented step of revoking HCQ’s emergency authorization,58 rendering that enormous stockpile of valuable pills off limits to Americans while conveniently indemnifying the pharmaceutical companies for their inventory losses by allowing them a tax break for the donations. After widespread use of the drug for 65 years, without warning, FDA somehow felt the need to send out an alert on June 15, 2020 that HCQ is dangerous, and that it required a level of monitoring only available at hospitals.59 In a bit of twisted logic, Federal officials continued to encourage doctors to use the suddenly-dangerous drug without restriction for lupus, rheumatoid arthritis, Lyme and malaria. Just not for COVID. With the encouragement of Dr. Fauci and other HHS officials, many states simultaneously imposed restrictions on HCQ’s use.

While we respect whatever treatment decisions people make, we do not define ourselves as essentially diseased, disordered, broken, faulty, and existing within the bounds of DSM-IV diagnosis. We are exploring unknown territory and don’t steer by the default maps outlined by docs and pharma companies. We’re making new maps.” This affirmation that the so-called mentally

In “Is Drug Research Trustworthy?” Charles Seife ferrets out doctors’ financial ties to pharma companies; in “Studying Drugs in All the Wrong People,” Gabriella Rosen breaks down why drug trials for psychiatric medications might be doing more harm than good to the people that need these

In 2008 Pfizer, a pharma company, undertook a huge self-examination under the heading PfizerWorks. It realised that its most highly skilled workers were spending 20% to 40% of their time on routine work—entering data, producing PowerPoint slides, doing research on the web. The company now contracts out much of this work.

One exemplar of that pending disruption is teenager Jack Andraka, who at the age of fourteen single-handedly developed an early-stage detection test for pancreatic cancer that costs just three cents. His approach (awaiting peer review) is 26,000 times cheaper, 400 times more sensitive, and 126 times faster than today’s diagnostics. Big Pharma has no idea how to deal with Jack, who is one of many wunderkinds emerging globally, all of them with the potential to disrupt great companies and long-established industries. The Jacks of the world bring exponential

According to International Diabetes Foundation, diabetes had long moved from being “a rich man’s disease”. With diabetes now affecting all the segments of Indian population, India stands on the verge of becoming “the diabetes capital of the world” with around 61 million people affected by the disease and expecting to cross 100 million people by 2030. Given the scale of diabetes epidemic, the NPPA justified its price control orders. On hearing the above, all hell broke loose in the Indian Pharma. The Indian pharma industry reacted very aggressively to this decision. Both Indian and multinationals raised concerns that “India’s investment image” had gone to the dogs and that the industry would have to shut down if the same trend continues. The Indian pharma lobbies also filed in the Delhi and Bombay High Courts, and prayed for a stay order which they were not granted, as many Supreme Court judgments had earlier justified price controls on medicines in public interest Modi’s Government rescues India’s Investment Image Given the relentless Industry demands, the Modi government decided to clip the wings of NPPA which was supposedly an expert body of regulators and withdrew their powers to pass such orders in the future. The decision of Modi government to withdraw the powers of the National Pharmaceutical Pricing Authority (NPPA) to set price caps on drugs raises serious questions on the state’s commitment to the welfare of the poor. As a result, over 108 essential drugs will now lie outside the ambit of NPPA and its internal guidelines on regulation and control of drugs would cease to apply to them. According to the government, the reasoning for withdrawal of powers of NPPA and clipping of its wings was because “it lacked legality”. Interestingly, the Modi government has found that NPPA was not legally competent to pass price control orders after over 17 years of its creation and immediately after it passed orders that would restrain pharma companies from making super normal profits.

Unfortunately, when all you can think about from sun up to sun down is how much you’re afraid of turning Shroom, you’re not in the best negotiating position. The Pharma company says, “Hey, I wanna fuck you over,” and all you can really say is, “Here, fuck my sister too.

Many of the best biotech and pharma companies today have learned to separate the roles of inventor and champion. They train people for the project champion job—the Deak Parsons skill-set—and elevate their authority. It goes against the grain. On the creative side, inventors (artists) often believe that their work should speak for itself. Most find any kind of promotion distasteful. On the business side, line managers (soldiers) don’t see the need for someone who doesn’t make or sell stuff—for someone whose job is simply to promote an idea internally. But great project champions are much more than promoters. They are bilingual specialists, fluent in both artist-speak and soldier-speak, who can bring the two sides together.

The real perfect storm fueling the opioid epidemic had been the collapse of work, followed by the rise in disability and its parallel, pernicious twin: the flood of painkillers pushed by rapacious pharma companies and regulators who approved one opioid pill after another. Declining workforce participation wasn't just a rural problem anymore; it was everywhere, albeit to a lesser degree in areas with physicians who prescribed fewer opioids and higher rates of college graduates. As Monnat put it: "When work no longer becomes an option for people, what you have at the base is a structural problem, where the American dream becomes a scam." She likened the epidemic's spread not to crabgrass but a wildfire: "If the economic collapse was the kindling in this epidemic, the opiates were the spark that lit the fire." And the helicopters were nowhere in sight.

As we have seen, drugs regulators don't require that new drugs are particularly good, or an improvement on what came before; they don't even require that drugs are particularly effective.

[T]here's room for a small cottage industry, if there are any academics feeling brave enough to pursue the project. Someone somewhere needs to identify all the studies where the main outcomes have been switched, demand access to the raw data, and helpfully, at long last, conduct the correct analyses for the original researchers. If you choose to do this, your published papers will immediately become the definitive reference on these trials, because they will be the only ones to correctly present the pre-specified trial outcomes. The publications from the original researchers will be no more than a tangential and irrelevant distraction. ¶ I'm sure they'll be pleased to help.

About a quarter of the money taken by pharmaceutical companies for the drugs they sell is turned around into promotional activity which has, as we will see, a provable impact on doctors' prescribing. So we pay for products, with a huge uplift in price to cover their marketing budgets, and that money is then spent on distorting evidence-based practice, which in turn makes our decisions unnecessarily expensive, and less effective.

Food animals also get antibiotics for “growth promotion,” a metabolically mysterious process that has made possible the entire high-volume, low-margin business of industrial-scale farming. Since the 1950s, when two pharma company scientists discovered that feeding chicks the waste products from drug manufacturing made them put on weight much faster, many U.S. farmers have been giving tiny doses of antibiotics to cattle, swine, and poultry.34

pharmaceutical companies spend tens of billions of pounds every year trying to change the treatment decisions of doctors: in fact, they spend twice as much on marketing and advertising as they do on the research and development of new drugs. Since we all want doctors to prescribe medicine based on evidence, and evidence is universal, there is only one possible reason for such huge spends: to distort evidence-based practice.

From the outset, hydroxychloroquine (HCQ) and other therapeutics posed an existential threat to Dr. Fauci and Bill Gates’ $48 billion COVID vaccine project, and particularly to their vanity drug remdesivir, in which Gates has a large stake.1 Under federal law, new vaccines and medicines cannot quality for Emergency Use Authorization (EUA) if any existing FDA-approved drug proves effective against the same malady: For FDA to issue an EUA (emergency use authorization), there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition. . . .2 Thus, if any FDA-approved drug like hydroxychloroquine (or ivermectin) proved effective against COVID, pharmaceutical companies would no longer be legally allowed to fast-track their billion-dollar vaccines to market under Emergency Use Authorization. Instead, vaccines would have to endure the years-long delays that have always accompanied methodical safety and efficacy testing, and that would mean less profits, more uncertainty, longer runways to market, and a disappointing end to the lucrative COVID-19 vaccine gold rush. Dr. Fauci has invested $6 billion in taxpayer lucre in the Moderna vaccine alone.3 His agency is co-owner4 of the patent and stands to collect a fortune in royalties. At least four of Fauci’s hand-picked deputies are in line to collect royalties of $150,000/year based on Moderna’s success, and that’s on top of the salaries already paid by the American public.5,6

Dr. Fauci must have recognized that since vaccine makers had immunity from liability [which he had helped arrange] and were playing, as it were, with house money [which he diverted to them through NIH], these companies had little incentive to invest in the kind of long-term studies necessary to eliminate the pathogenic priming hazard.

3) Third, Dr. Fauci’s trump card was his capacity to enlist mainstream and social media companies to make reporting of injuries and deaths disappear from the airwaves, newspapers, and the Internet, and therefore from the public consciousness.

Under federal law, new vaccines and medicines cannot quality for Emergency Use Authorization (EUA) if any existing FDA-approved drug proves effective against the same malady: For FDA to issue an EUA (emergency use authorization), there must be no adequate, approved, and available alternative to the candidate product for diagnosing, preventing, or treating the disease or condition. . . .2 Thus, if any FDA-approved drug like hydroxychloroquine (or ivermectin) proved effective against COVID, pharmaceutical companies would no longer be legally allowed to fast-track their billion-dollar vaccines to market under Emergency Use Authorization. Instead, vaccines would have to endure the years-long delays that have always accompanied methodical safety and efficacy testing, and that would mean less profits, more uncertainty, longer runways to market, and a disappointing end to the lucrative COVID-19 vaccine gold rush. Dr. Fauci has invested $6 billion in taxpayer lucre in the Moderna vaccine alone.3 His agency is co-owner4 of the patent and stands to collect a fortune in royalties. At least four of Fauci’s hand-picked deputies are in line to collect royalties of $150,000/year based on Moderna’s success, and that’s on top of the salaries already paid by the American public.5

A recent study by two York University researchers found that Big Pharma spends nearly twice as much on promotion and advertising as it does on research and development.

Google’s parent company Alphabet owns several vaccine companies, including Verily, as well as Vaccitech, a company banking on flu, prostate cancer, and COVID vaccines.50,51 Google has lucrative partnerships with all the large vaccine manufacturers, including a $715 million partnership with GlaxoSmithKline.

Henrique Dubugras, the co-founder of Brex, told me he was most excited about companies focused on rebuilding insurance. Mario Schlosser, the co-founder of Oscar Health, pointed to the wealth of opportunities still left to revamp healthcare. Max Mullen, who co-founded Instacart, raved about the future of food; Max Levchin of Affirm and PayPal talked about the importance of “clean water, access to food, climate change, and improvement in education.” For Neha Narkhede of Confluent, it was “the consumerization of the enterprise,” meaning a bottom-up adoption of tools to make enterprise sales happen. Michelle Zatlyn, the co-founder of Cloudflare, was excited about the future of social networks. And on the life science and healthcare side, Arie Belldegrun of Kite Pharma was excited about cell therapy, while Nat Turner of Flatiron Health was keen on the application of data in “neurology, neurodegenerative disease, and cardiovascular diseases.” The most interesting response came from Tony Fadell, the co-founder of Nest. “I think it’s more important to look at the markets than spaces and industries,” he told me. Beyond Silicon Valley, big changes are happening in India, in Southeast Asia, and across Latin America. “These places are going through massive transitions, just like China has already. You need to pay attention to these new markets and see what unique problems you can solve for these markets. You always need to think in the context of the problems of the place you’re going after.

January 2016, Carla Stouffer, a seventy-one-year-old retiree, would have simply swallowed her daily capsule for high blood pressure, amlodipine/benazepril, were it not for a flash of movement. On closer inspection, she noticed a small, centipede-like bug stuck halfway inside the capsule, alive and wiggling. Horrified, she watched as the bug tried to free itself from the pill casing. She’d never thought before about who made her medicine. But she learned that the maintenance drug, which she’d gotten in a three-month supply from the prescription benefit manager Express Scripts, was made by the Indian company Dr. Reddy’s Laboratories.

I sometimes joke that the only way to define mental disorder is “that which clinicians treat; researchers research; educators teach; and insurance companies pay for.

Pharma Company for Antimicrobial Drugs Are you looking for PCD Pharma Franchise? Vita Pharmaceuticals is India's best PCD Pharma Franchise. Here are some best benefits to join us. -Quality Range -Best Bulk Rates -Timely Delivery -Economical Plans Pharma Company for Antimicrobial Drugs, Antimicrobial Drugs Company We are one of the best Pharmaceutical Companies engaged in manufacturing high-grade pharmaceutical drugs, Antimicrobial Drugs, Antimicrobial Drugs Company in India. We undertake our quest of improving the quality of human life with enthusiasm and vigour. Our vision for the future is powered by our business drivers. It finds purpose and direction with our strategic intent. Understanding how diseases develop and the preventive measures that can be adopted to avoid them are important steps in staying healthy.

PCD & Franchise Company, International Standard Quality Products in Ahmedabad Gujarat India. Desta Life Sciences is the top PCD Pharma Franchise company in India. We are procured from faithful vendors to ensure its International Standard Quality Products. We're at Desta Science for Health Life providing the best PCD Franchise for business. This is the best Business Opportunity in India. We have 200+ Products, 4 Divisions and 13 Innovative Products. Desta Lifesciences, Started in 2011. The company's philosophy has been rooted in Quality and care and it is this ideology that has kept us alive through ups and downs. The company's greatest asset has always been its employees and it is in them we place our trust to shoulder the company's corporate responsibility and to uphold the company's ideals and values. A healthy blend of World-Class Quality, Disease prevalence-dependent, wide variety of products, stress on preventive Lifestyle products, a positive upbeat mood of one & all in the company and a feeling of oneness, is the recipe that Desta Lifesciences presents humbly to humanity. The "For the people, By the People" dictum is followed by the management in the company, thus making it surge forward with the force of the common goal to accomplish our Mission. We aim to serve mankind globally through our affordable and international standard quality products, encompassing the environmental synergy in the process. As we enter into the technological age of pharmaceuticals, we promise to adapt to more advanced technologies while simultaneously focusing on delivery of care. The future holds great promise as we gradually hope to venture into Exports and R&D to establish ourselves in the global market.

We are a growing Pharmaceutical Distributors Company in India. we offer Pharma PCD, Pharma Franchise, distributorship and top Best PCD Pharma Companies in India. Vita Pharmaceuticals is a leading PCD Pharma Company in India. We are the fastest growing Pharmaceutical Company of PCD Pharma Franchise Company in Ahmedabad India.

Tesni Pharmaceuticals offers the best PCD pharma franchise in Ahmedabad and all other regions of India. Tesni pharma always strives to maintain the optimum quality standards of drugs and medicines.

Dr. Fishbein had entered a dangerous realm at NIAID. He was interfering with ongoing drug approvals. Tramont was angry that Dr. Fishbein was allowing concerns about patient safety to become an obstacle to the agency’s central mission of getting new drugs through the approval process with positive reviews. Tramont warned Dr. Fishbein to slow down. “You are moving too fast. You need to get to know how this place works,” Tramont told him. “We need to act more like a pharmaceutical company; we need to get patients, and get studies done.

By acting like the good guys, as Wokenomics demands they do, pharma companies are actually able to get away with behavior that leaves society worse off in the end.

Dr. Fauci presided over these atrocities, collaborating with pharmaceutical company researchers and winking at their loose definitions of “informed consent” and “volunteer.” Instead of looking out for the best interests of children, Dr. Fauci gave outlaw drug makers56 free rein to torture vulnerable children behind closed doors, with neither parental permission nor requisite oversight from child welfare authorities.

The “J. Edgar Hoover of public health” has presided over cataclysmic declines in public health, including an exploding chronic disease epidemic that has made the “Fauci generation”—children born after his elevation to NIAID kingpin in 1984— the sickest generation in American history, and has made Americans among the least healthy citizens on the planet. His obsequious subservience to the Big Ag, Big Food, and pharmaceutical companies has left our children drowning in a toxic soup of pesticide residues, corn syrup, and processed foods, while also serving as pincushions for 69 mandated vaccine doses by age 18—none of them properly safety tested.55 When Dr. Fauci took office, America was still ranked among the world’s healthiest populations. An August 2021 study by the Commonwealth Fund ranked America’s health care system dead last among industrialized nations, with the highest infant mortality and the lowest life expectancy.

outlets including HuffPost, Politico, and The Daily Beast.86 Media platforms uniformly identify Offit as a “vaccine expert” from the University of Pennsylvania and the Children’s Hospital of Philadelphia (CHOP). With Offit’s encouragement, they seldom, if ever, disclose his pervasive financial entanglements with Dr. Fauci and the pharmaceutical companies.

The NCI scientists pointedly added that the company’s squeamishness about handling the HIV pathogens made it impossible for Burroughs Wellcome to perform any meaningful research: “Indeed one of the key obstacles to the development of AZT was that Burroughs Wellcome did not work with live AIDS virus nor wish to receive samples from AIDS patients.

Under Dr. Fauci’s management, NIAID has become the center of a web of corrupting financial ties with the pharmaceutical industry. Dr. Fauci’s NIAID looks much more like a drug company than any sort of agency to advance science.

Today, Pharma still regards Africa as the beau ideal to test immunizations, and as a lucrative receptacle for dumping expired and defective stocks.5 Bill Gates has played a key role in legitimizing this arrangement while collaborating with captive or corrupt WHO officials to scam Western donor nations into footing the bill, and guaranteeing rich profits for pharmaceutical companies in which, coincidentally, he holds hefty stock positions. Gates—the “biggest funder of vaccines in the world”6—is heavily invested in lucrative partnerships with almost all the world’s largest vaccine companies.7 Bill and Melinda Gates have continued the tradition of human experimentation in Africa with the WHO stepping neatly into the role of an enabling colonial vassal.

In 2003, a law slid through Congress stipulating that Medicare, the world’s largest drug buyer, could no longer negotiate prices with corporations. The statute directed them to pay 106 percent of the companies’ average wholesale price.

PCD Pharma Franchise on a Monopoly Basis Getting PCD Pharma Franchise Monopoly Basis is now easier than ever, thanks to Saphnix Medicure. We always believe in building a good relationship with our franchise owners and going the extra mile to keep them happy and satisfied with their work. See what one of our franchise owners says. "As a Pharma franchisee, I made the best decision of my life by choosing Saphnix Medicure's PCD Pharma Franchise; they have all the factors that a Pharma Franchise company should possess; effective products, market demand, a good reputation, and good behaviour towards franchisees! The best pharma franchise in India! Lovely experience." Salient features: * 24*7 Support * WHO, GMP Certified Company * 400 + Products * Dispatch within 24 hrs I know what you are thinking. How to get in touch, right? Give us a call or email. So what are you waiting for? Contact Saphnix Medicure today. Call us :- +91 70567 56400

A Supreme Court decision (Riegel v. Medtronic, Inc., 552 US 312, 2008) protected devices from most lawsuits. It exempts the companies from litigation if the FDA agreed on the device’s effectiveness and safety during the approval process. When the drugmakers have issues, they may have to defend lawsuits, but this Supreme Court decision protects the appliance manufacturers.

Third Party Manufacturing Pharma Company In Ahmedabad Saphnix Lifesciences is the best Third Party Manufacturing Pharma Company In Ahmedabad. With numerous ongoing manufacturing projects, we have certainly done our best to comply with our customers' demands. We plan to expand our horizons and look beyond what we have accomplished so far. Be it Third party Manufacturing or Offering Franchise, we have succeeded in each project. In our case, as a self-owned organization, we have access to a fully equipped technology system. In a secure warehouse with hygienic packaging, finished goods are stored. The manufacturers of houses design them following their temperature, humidity, and ventilation requirements. It is divided into sections for filter washing, drying, and storage. So what are you waiting for? Saphnix is only one call away!

the drug companies had to get an indication for bipolar disorder and then they had to advertise a conception of bipolar disorder so broad as to be unrecognizable. Antipsychotics were soon being prescribed promiscuously, even by primary care physicians, to patients with garden-variety anxiety, sleeplessness, and irritability.

Much of the increased prevalence of ADHD results from the “false positive” misidentification of kids who would be better off never receiving a diagnosis. Drug company marketing pressure often leads to unnecessary treatment with medications that can cause the harmful side effects of insomnia, loss of appetite, irritability, heart rhythm problems, and a variety of psychiatric symptoms.

Pharmaceutical Syrup Manufacturers Saphnix Life Sciences is an emerging and fastest-growing Pharmaceutical Syrup Manufacturers. Our company is well based in Chandigarh and popular for its best high-quality wide range of Syrup range. We the best Syrup Range Manufacturer in India are capable of carrying out large-scale manufacturing and supplying various varieties of syrups/suspension ranges to many pharma companies all around India. WE FOLLOW THE LATEST AND MOST ADVANCED SYRUP MANUFACTURING TOOLS Our company has built its modern, fully developed infrastructure. Maximum possible use of technology and sources lead us to manufacture medicines cost-effectively. To obtain pure, safe, and non-contaminated medicines, we use sterilized machinery to manufacture and package the medicines. The company is using all the quality methods for syrup/suspension manufacturing. Different manufacturing tools for syrup include- 1. Control Panel 2. Product Piping 3. Storage Vessel 4. Working Platform 5. Sugar Syrup Vessel 6. Manufacturing Vessel Salient Features In addition to the above, you can also choose us for these reasons: • -On-time delivery • -Year around stock availability • -24*7 customer support • -Quality medicinal drugs • -Appealing packaging Saphnix Lifesciences: Proudly the best Pharmaceutical Syrup manufacturer in India.

Medical-industrial complex” paints the picture of a firing squad, except the squad is disorganized, each of the gunmen—the insurance companies, doctors, hospitals, and Big Pharma—aiming not only for us but also for the other gunmen.

Once the product gets to market, the pharmaceutical company pays royalties—a form of legalized kickbacks—through an informal scheme that allows Pharma to funnel its profits from drug sales to NIAID and to the NIAID officials who worked on the product. Under a secretive, unpromulgated HHS policy, Dr. Fauci and his NIAID underlings may personally pocket up to $150,000 annually from drugs they helped develop at taxpayers’ expense

A leviathan yearly grant budget gives Dr. Fauci power to make and break careers, enrich—or punish—university research centers, manipulate scientific journals, and to dictate not just the subject matter and study protocols, but also the outcome of scientific research across the globe. Since 2005, the Defense Advanced Research Projects Agency (DARPA) has funneled an additional $1.7 billion3 into Dr. Fauci’s annual discretionary budget to launder sketchy funding for biological weapons research, often of dubious legality. This Pentagon funding brings the annual total of grants that Dr. Fauci dispenses to an astonishing $7.7 billion—almost twice the annual donations of the Bill & Melinda Gates Foundation. Working in close collaboration with pharmaceutical companies and other large grant makers, including Bill Gates—the biggest funder of vaccines in the world—Dr. Fauci has consistently used his awesome power to defund, bully, silence, de-license, and ruin scientists whose research threatens the pharmaceutical paradigm, and to reward those scientists who support him. Dr. Fauci rewards loyalty with prestigious sinecures on key HHS committees when they continue to advance his interests. When the so-called “independent” expert panels license and recommend new pharmaceuticals, Dr. Fauci’s control over these panels gives him the power to fast-track his pet drugs and vaccines through the regulatory hurdles, often skipping key milestones like animal testing or functional human safety studies. Dr. Fauci’s funding strategies evince a bias for developing and promoting patented medicines and vaccines, and for sabotaging and discrediting off-patent therapeutic drugs, nutrition, vitamins, and natural, functional, and integrative medicines. Under his watch, drug companies engineered the opioid crisis and made American citizens the globe’s most over-medicated population.

It’s no surprise that a 2004 Office of Government Ethics investigation chided Dr. Fauci for failing to control the corrupting entanglements between his staffers and pharmaceutical companies.11,12 That report cited NIAID for failing to review and resolve possible ethical conflicts affecting two-thirds of NIAID’s workers who were moonlighting in private industry.

The August 2000 Congressional investigation found that the majority of ACIP members were conflicted in that vote.103 That report found that seven out of ten ACIP working group committee members who voted to approve the rotavirus vaccine in June 1998 had financial ties to the pharmaceutical companies that were developing different versions of the vaccine. According to